The Federal Trade Commission has cleared a healthcare deal from antitrust concerns.
The FTC granted early termination status to Nashville-based Emdeon's $260 million acquisition of Chamberlin Edmonds & Associates, which was announced this month. Atlanta-based Chamberlin Edmonds provides government program eligibility and enrollment services to healthcare providers.
By granting “early termination status,” the FTC will not subject the deal to further review under the Hart-Scott-Rodino Act.
The acquisition will help Emdeon, which operates a claims clearinghouse and provides financial management software to healthcare providers and payers, prepare for increased Medicaid enrollment as a result of healthcare reform, according to a news release issued when the deal was announced.